Share Holders Profile

KILITCH DRUGS (INDIA) LTD
Kilitch Drugs (India) Ltd was incorporated in the year 1978 by entrepreneur- Late Mr. Pratap Mehta having a rich experience of more than 30 years at the time, Kilitch seized early opportunities with its sound knowledge of the industry. Today with more than three decades of successful pharmaceutical solutions, new markets, partnerships and enhancements have made Kilitch stronger and more Customer-centric.Kilitch Drugs (India) Ltd was incorporated in the year 1978 by entrepreneur- Late Mr. Pratap Mehta having a rich experience of more than 30 years at the time, Kilitch seized early opportunities with its sound knowledge of the industry. Today with more than three decades of successful pharmaceutical solutions, new markets, partnerships and enhancements have made Kilitch stronger and more Customer-centric.

ESTRO IMPORT & EXPORT PVT LTD CO
Estro Import and Export Pvt Ltd Co. was established in Ethiopia in 2011 by two brothers (Mr Daniel & Mr Samuel Waktole & Family). The two brothers have established the company with a great desire and passion to enter into pharmaceutical manufacturing which has come to a reality within just 10 years of the company’s establishment with a joint venture with Kilitchh Drugs India Ltd.
The Synergy of Expertise
Our Strategic Partnership
The foundation of Kilitch Estro Biotech PLC is a powerful synergy between global pharmaceutical expertise and deep local market knowledge. Our joint venture brings together decades of manufacturing excellence with a commitment to Ethiopia’s healthcare sovereignty.
A Joint Investment for Local Production
Kilitch Estro Biotech PLC (KEBPLC) was established in 2015 to create Ethiopia’s first sterile cephalosporin manufacturing plant. Formally equity-partnered on August 9, 2017, this collaboration represents a direct investment in the nation’s pharmaceutical future.
Ownership Structure
This ownership model ensures aligned long-term goals, combining capital, technology, and local expertise to achieve sustainable healthcare manufacturing.
Foreign Equity (67%):
Providing global capital and advanced manufacturing technology.
Local Equity (33%):
Providing deep local expertise and market integration.
This ownership model ensures aligned long-term goals, combining capital, technology, and local expertise to achieve sustainable healthcare manufacturing.
A Joint Investment for Local Production
Kilitch Estro Biotech PLC (KEBPLC) was established in 2015 to create Ethiopia’s first sterile cephalosporin manufacturing plant. Formally equity-partnered on August 9, 2017, this collaboration represents a direct investment in the nation’s pharmaceutical future.
Ownership Structure
Rooted in Community
Our Shared Commitment
Community Water Supply
Providing clean water access for ~700 households and a local army camp.
Education & Training
Hosting internships and practical training for Ethiopian pharmacy university students.
Local Infrastructure
Active support for the local police station and community-owned shops.